This article reviews and discusses the clinical, pathologic, and radiographic features of a group of systemic diseases which share pulmonary and renal abnormalities. Emphasized are similarities and differences in the clinical and chest radiographic manifestations of Goodpasture's syndrome, Wegener's granulomatosis, lymphomatoid granulomatosis, Churg-Strauss syndrome, systemic lupus erythematosus, and scleroderma. Wegener's granulomatosis, lymphomatoid granulomatosis, and ChurgStrauss syndrome are each considered under one category of diseases with pulmonary/ renal pathology, the systemic granulomatous vasculitides. Systemic lupus erythematosus and scleroderma belong to a group of disorders known as the connective tissue diseases. However, all six of these diseases have in common the propensity to present with pulmonary abnormalities which may provide problems in differential diagnosis. It is our purpose to detail the characteristics of these diseases, particularly the pulmonary findings, which aid in diagnosis and management. GOODPASTURE'S SYNDROME Goodpasture's syndrome is characterized by pulmonary hemorrhage with hemoptysis, diffuse alveolar filling on the. chest radiograph, anemia, and glomerulonephritis (often rapidly progressive) [1] [2] [3] . Wilson and Dixon [6] extended this definition to include the presence of antiglomerular basement-membrane (anti-GBM) antibodies, which are found in most patients with Goodpasture's syndrome [6, 10, 11] . Clinical and experimental studies suggest that the disorder usually is caused by such antibodies reacting with both glomerular and alveolar basement membranes [6, 8, 9] .
While the catalyst is unknown, production of these antibodies is usually self-limited [6] , and the syndrome apparently is inactive when the antibody is not detected [6, 13] .
Clinico-Pathologic Features
Early reports on Goodpasture's syndrome indicated a marked male predominance of 9:1 [1] , but more recent studies describe lower male-to-female ratios of 3.5:1 [14] 497 and 2:1 [3] . Seventy-five percent of patients are between the ages of 17 and 27 years at the onset of the illness [3, 15, 16] , while the remainder range in age up to 75 years [3] .
In most cases, the initial symptom is hemoptysis which occurs at some point during the course of the disease in 99 percent of cases [1, 3] . Bouts of hemoptysis range in severity from slightly blood-streaked sputum to massive hemorrhage [1] . In about one-fifth of the patients, upper respiratory tract infections of a non-specific (viral) nature precede the appearance of the syndrome [1] . Chills and fever occur acutely with pulmonary hemorrhage but are not otherwise prominent. Substernal chest pain occurs without relation to activity, although it can be aggravated by coughing.
Renal abnormalities may occur before pulmonary symptoms. In the Wilson and Dixon study, 8 of 32 patients initially had renal abnormalities 0.2 to 13 months before pulmonary symptoms [6] . Urinary findings, present on admission in over 80 percent of patients [3] , include proteinuria, microscopic hematuria, and, less commonly, pyuria [ 1, 3, 6] . In 26 of Wilson and Dixon's patients (81 percent), renal failure requiring dialysis occurred within one to 14 months of onset (mean 3.5 months) [6] .
Anemia is universally present early in the disease [1, 3] . In Benoit's review [1] , initial hemoglobin levels averaged 7.7 g/ 100 ml (range, 3.8 to 14.5), with the lowest levels usually related to severe pulmonary hemorrhage. The anemia is apparently not hemolytic, although a decreased erythrocyte life span has been demonstrated [1] . Neither hemolysis nor jaundice is present.
Chest Radiographic Findings The radiographic appearance of Goodpasture's syndrome (Figs. 1,2) is closely related to the distribution, volume, and time sequence of pulmonary hemorrhage. Both interstitial and alveolar involvement occur [4] . Confluent densities are seen shortly after hemorrhage and may be indistinguishable from hypervolemia associated with azotemia or from noncardiogenic pulmonary edema of other origin. All these conditions produce rapid alterations in the chest radiograph. Localized air space changes may progress to diffuse opacification within hours, while complete clearing may occur during remission. However, accentuated interstitial markings tend to persist in Goodpasture immunogenic [6] . Environmental factors also may work in a non-antigenic way; noxious stimuli (infectious or chemical) might alter the anatomic integrity of the lung and expose basement membrane antigens, which normally are sequestered from the circulation [6] .
Therapy and Prognosis
The prognosis for Goodpasture's syndrome is generally poor. Fifty of the 52 patients in Benoit's 1964 review died, 23 of renal failure and 27 of lung hemorrhage [1] . In Wilson and Dixon's study [6] , in which the diagnosis was based on the presence of circulating anti-GBM antibodies, 28 of 32 patients developed renal failure and over one-half died within one year of diagnosis.
The most promising therapy includes plasmapheresis and immunosuppressive therapy with cyclophosphamide and prednisone [13, [25] [26] [27] [28] [29] . Because of the lack of controlled studies, the exact effects of this combined therapy are not clear. Since production of anti-GBM antibodies may be short-lived, plasma exchange should reduce damage to the glomerulus by lowering the levels of circulating antiglomerular basement membrane antibody. Lockwood et al. [13] reported on seven patients treated with plasma exchange, cytotoxic drugs, and corticosteroids. Renal function improved in three who were not already receiving dialysis at the initiation of therapy. Five patients had pulmonary hemorrhage, which appeared to respond to therapy. These investigators reported that although the fall in anti-GBM antibody titer was variable, there was also depletion of fibrinogen and complement. They believed that the reduction of the latter two substances could have been important therapeutically. Swainson et al. [29] noted a rebound increase in anti-GBM antibody levels following periods of plasma exchange. They concluded that plasma exchange was only effective in substantially reducing the circulating amounts of complement or fibrinogen when performed on consecutive days. The rapid rise in concentrations after exchange reflects rapid turnover and distribution from extravascular pools.
In general, plasma exchange may be useful in the early treatment of severe forms of Goodpasture's syndrome by controlling pulmonary hemorrhage and preventing irreversible renal damage from the high anti-GBM antibody levels. However, the removal of anti-GBM antibodies does not lead to recovery of renal function. Furthermore, there is considerable variation in the amount of reduction of anti-GBM levels in the serum produced by serial plasma exchange and immunosuppression. A controlled clinical study is urgently needed to justify the considerable expense of extensive plasma exchange before its wider use can be encouraged. SYSTEMIC GRANULOMATOUS VASCULITIDES: WEGENER'S GRANULOMATOSIS Wegener's granulomatosis has a distinctive clinico-pathologic triad of necrotizing granulomatous vasculitis of the upper and lower respiratory tracts, glomerulonephritis, and variable degrees od disseminated small vessel vasculitis [7, [30] [31] [32] . A localized form of Wegener's limited primarily to the respiratory tract has been reported [7, 33] but probably represents an early stage that, if not treated, eventually would involve the kidney and become a generalized Wegener's. However, some patients may have a "forme fruste" of the disease that never disseminates [7] .
Clinico-Pathologic Festures
Wegener's granulomatosis can occur at any time, but the average age of onset is 40 years. The disease occurs in males twice as frequently as in females [7] .
Initially, clinical presentations vary widely among patients, but generally are related to the upper respiratory tract. Typical findings include rhinorrhea, severe sinusitis, and, frequently, nasal mucosal ulcerations and otitis media, usually secondary to blockage of the eustachian tube resulting from upper airway disease [7] . Some patients present with primary middle ear disease, and hearing lossmay be the initial complaint [7] . Fever occurs in almost 80 percent of cases, but in approximately one-half, it is secondary to a detectable infection, usually of the paranasal sinuses [30] .
Pulmonary symptoms include cough, hemoptysis, and, less frequently, chest discomfort [7, 30] . Pulmonary function studies generally show loss of lung volumes with a restrictive ventilatory defect in association with significant parenchymal lesions [2] . More than 50 percent of patients with Wegener's also have an obstructive ventilatory abnormality that cannot be related to cigarette smoking [2] . In patients with obstructive changes, granulomatous lesions that have blocked an airway may be found during fiberoptic bronchoscopy. The presence of these lesions also may be suggested by abnormalities found on flow-volume curves.
Renal disease is the sine qua non of generalized Wegener's granulomatosis. Prior to the use of cytotoxic agents as therapy in this disorder, most patients succumbed to renal disease, with a mean survival of five months from the onset of clinically evident renal involvement [7] . The urinary findings in generalized Wegener's are those of acute glomerulonephritis with hematuria, red blood cells casts, and proteinuria.
Any of the other organ systems involved in Wegener's may also be the focus of initial complaints. Arthralgias frequently are part of the presenting symptomatology, as are other generalized manifestations of systemic inflammatory disease, such as fatigue, malaise, anorexia, and weight loss [7, 30] .
Wegener's granulomatosis presents a characteristic complex of laboratory findings. The mild anemia of subacute or chronic diseases is seen frequently, as is mild leukocytosis. Thrombocytosis (up to 1,000,000 platelets/mm3) can be present and probably represents an acute reaction [7] . Bentonite flocculation test findings are mildly elevated in about 50 percent of patients, whereas results of antinuclear antibody and lupus erythematosus (LE) cell preparation tests are uniformly negative. Whole complement levels are normal or mildly elevated. Mild hyperglobulinemia, particularly involving the serum immunoglobulin A fraction, occurs commonly [34] . Almost all patients have strikingly elevated erythrocyte sedimentation rates, usually 100 mm/hour or more (Westergren method) [7] .
Chest Radiographic Manifestations The pulmonary infiltrates of Wegener's granulomatosis are heterogeneous, and may be any size, shape, or lobar location (Figs. [3] [4] [5] [2, 7, [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] . The most characteristic, although not the most common, patterns are solitary (Fig. 5) or multiple nodular densities (Figs. 3,4) or infiltrates, either poorly defined or sharply circumscribed [2, 30] . These opacities vary in size from less than 1 cm to greater than 9 cm [30, 36, 37] . The infiltrates may be unilateral, but usually involve both lungs [37] . Unilocular or multilocular cavitation with irregular walls is common [30, 36, 37] , and occasionally air-fluid levels are found [38] . Some investigators have described these cavities as thick-walled [36] , but others [37] maintain that thin-walled cavities are the rule. They suggest that the walls appear thick on plain chest films due to infiltration of the surrounding lung. The infiltrates may be quite transient with one disappearing in one lung field and other appearing in a different location [37] .
Atypical radiographic manifestations of Wegener's include focal areas of collapse adjacent to infiltrates [37] and mediastinal lymph node enlargement [38] . The combination of hilar and-mediastinal adenopathy on the chest radiograph should suggest an alternate diagnosis [2] . Other occasional signs include bronchopleural fistula; narrow areas in the larger airways, which may lead to lobar collapse [39] ; and pleural thickening and pleural effusions [2, 36] . Maguire et al. [39] include vasculitic disorders such as polyarteritis nodosa; hypersensitivity vasculitis; the spectrum of connective tissue diseases; granulomatous diseases, such as sarcoidosis and midline granuloma; mixed granulomatous and vasculitis diseases, such as allergic granulomatosis; infectious granulomatous diseases, such as tuberculosis, leprosy, and fungal disease; Goodpasture's syndrome; and a variety of neoplasms accompanied by a granulomatous or vasculitis inflammatory response [7] . Open lung biopsy is the procedure of choice in approaching the pulmonary infiltrates of Wegener's granulomatosis. The outstanding pathologic feature in all cases is the presence of inflammatory masses (.5 to 5 cm) within the parenchyma of one or both lungs [44] . Generally, the masses are few and sharply circumscribed on gross examination. Microscopically, they consist of necrotic areas surrounded by zones of granulation tissue.
The earliest lesion in the kidney is a focal and segmental glomerulitis [7, 45] . If not treated properly, the lesions progress to a fulminant, necrotizing, and proliferative glomerulonephritis, and eventually can lead to renal failure. At very early stages, glomerulitis may go undetected because the urinary sediments and renal function may be normal. Therefore, percutaneous renal biopsies are recommended when there is a high index of suspicion of Wegener's, even when the urinary sediments are normal [7] . Renal biopsies not only aid in establishing a diagnosis, but also serve to monitor response to therapy as measured by subsequent biopsies.
Etiology and Pathogenesis
The etiology of Wegener's is unknown, although hypersensitive reaction to an unidentified antigen is strongly indicated [31] . Circulating immune complexes occur during the active process [46] , and immune reactants and complex-like deposits have been seen in some renal biopsies of patients with Wegener's granulomatosis and active glomerulonephritis [31, 30, 45] . The role of these immune complexes in the pathogenesis of the disease is not known.
Therapy and Prognosis
Untreated, Wegener's granulomatosis rapidly pursues a fatal course with a mean survival time of five months in most cases [47, 48] . Eighty-two percent of patients die within one year and more than 90 percent within two years. Although corticosteroids increase mean survival to 12.5 months [49] , the long-term prognosis is not signifi-cantly altered by this therapy, especially in patients with clinically apparent renal disease.
The current drug of choice in treating Wegener's granulomatosis is cyclophosphamide [2, 7, 30, 31, 34] . This drug produces long-term remission in most patients. The drug is administered orally or, in cases of rapidly progressive disease, intravenously. A clinical reponse is usually seen after one to three weeks of therapy. The dose of cyclophosphamide must be monitored continually and adjusted to keep the white blood cell count above 3,000 cells per mm3 [2, 31] .
In patients who cannot tolerate cyclophosphamide because of severe leukopenia or hemorrhagic cystitis, or in young women who are not willing to accept the ovarian damage associated with cyclophosphamide, azathioprine is an alternative cytotoxic agent. However, generally experience has shown that azathioprine is not as effective as cyclophosphamide [2, 31] .
SYSTEMIC GRANULOMATOUS VASCULITIDES: LYMPHOMATOID GRANULOMATOSIS Lymphomatoid granulomatosis is a systemic disease characterized by an angiocentric, angiodestructive, and lymphoreticular granulomatous vasculitis primarily of the lungs, but also frequently involving the kidneys (45 percent), skin (45 percent), and central nervous system (20 percent) [2, 41, 42, 50, 51] . Although any organ system can be involved, the spleen, lymph nodes, and bone marrow usually are spared. This disorder resembles an indolent lymphoma, and, in many instances, it progresses to an atypical disseminated lymphoproliferative disease (Fig. 8) The male-to-female ratio is about 2:1, and most patients are in early middle age [41, 51] . Lung involvement is a sine qua non of lymphomatoid granulomatosis and usually is manifested as multiple nodular infiltrates of various sizes that tend to cavitate [2, 41, 50, 51] . Most patients present with chest symptoms (cough and shortness of breath) or systemic complaints (fever, weight loss, malaise) or both. Presenting complaints in 142 cases are listed in Table 1 [50] .
Most patients have a normal or only slightly reduced hematocrit. In Katzenstein's series [50] , the presenting leukocyte count was normal in 50 percent, elevated in 30 [50] tlncludes nonspecific gastrointestinal complaints such as nausea and vomiting, diarrhea, and abdominal pain percent (range, 9,000-38,000), and reduced in 20 percent (range, 1,200-3,900). A relative lympocytopenia was noted in 33 percent and lympocytosis in 6 percent. Serum immunoglobulins were normal in 53 percent of cases and nonspecific increases, usually in IgG or IgM, were seen in the remainder [50] . Chest Radiographic Manifestations The chest radiographic manifestations of lymphomatoid granulomatosis (Figs. 6-8) depend in part on the duration of the disease. Lesions may appear and disappear without relation to therapy, as also occurs in Wegener's granulomatosis [2, 31, 41] . The pulmonary lesions predominate in the lower lung fields peripherally (Figs. 7,8A ) and are usually bilateral [41] . Typically, the early lesions present as multiple, bilateral, ill-defined densities [2, 50] . Later, they become better defined and resemble nodular metastases of various malignancies (Fig.  8B) [2, 41] . The lesions also may coalesce (Fig. 6B) , especially in the lung bases, and resemble a mass-like or pneumonic process [2] . Cavitation was seen in 30 percent of the original patients studied by Leibow et al. [51] . Hemorrhage secondary to cavitation was the cause of death in 14 percent of the 40 patients in this study [51] . Hilar adenopathy is unusual in lymphomatoid granulomatosis and occurs only in a few patients whose disease ultimately pursues the course of lymphoma [41] . Pleural effusions.may or may not be present (Fig. 7) .
Diagnosis involvement is unusual in lymphomatoid granulomatosis. In addition, renal involvement in lymphomatoid granulomatosis is a diffuse nodular infiltrate of the renal parenchyma with a characteristic cellular infiltrate in contrast to the necrotizing glomerulonephritis seen in Wegener's granulomatosis [7, 41, 47, 51] . Leukopenia and anergy before therapy are rare in Wegener's but are seen frequently in lymphomatoid granulomatosis [3, 31] . Also, contrary to the condition of patients with Wegener's granulomatosis [30, 31, 34] , the erythrocyte sedimentation rate may be normal in some patients during disease activity [47] . Etiology and Pathogenesis The etiology of lymphomatoid granulomatosis is unknown. It may be an acquired abnormality of the lymphocyte in a susceptible host, such as Sjogren's syndrome [53] .
Evidence for this includes absent delayed hypersensitivity as demonstrated by nonreactivity to skin test antigens and the response of the lung lesions to the corticosteroids [52] . As in Sjogren's syndrome, lymphomatoid granulomatosis can terminate in a neoplastic disease [51, 52] .
Other disease, such as lymphoma and mycosis fungoides, can have years of symptoms with a biopsy showing nonspecific lymphoid and plasma cell infiltrates before it assumes the usual features of a neoplastic disease. Renal homotransplantation can be followed by lymphoreticular proliferation with involvement of the central nervous system [54] [55] [56] . Antigenic exposure in an immunosuppressed host may alter the cell membrane and produce an auto-immune disease [51, [57] [58] [59] [60] [61] [62] [63] . With continued immunosuppression, neoplastic disease may result [64, 65] . Therapy and Prognosis Untreated, lymphomatoid granulomatosis is usually rapidly progressive and fatal [31] . Death is often related to pulmonary or central nervous system complications [51] . Nevertheless, preliminary reports indicate that a relatively high rate of longterm remissions can be achieved if patients are treated early with cyclophosphamide and corticosteroids in the same regimen as used for Wegener's granulomatosis [66] .
SYSTEMIC GRANULOMATOUS VASCULITIDES: ALLERGIC ANGIITIS AND GRANULOMATOSIS (CHURG-STRAUSS STYNDROME)
Churg and Strauss [67] in 1951, and Rose and Spencer [68] in 1957, described an uncommon granulomatous inflammation and vascular necrosis primarily involving the heart, lungs, skin, nervous system, and kidneys. This entity, commonly referred to as allergic angiitis and granulomatosis, occurs primarily in patients with an allergic background or asthma or both.
Clinico-Pathologic Features
In 30 cases of the Churg-Strauss syndrome reported by Chumbley [69] , 21 were men and nine were women. Ages ranged from 15 to 69 years; the average was 47. The mean duration of asthma was eight years. It began at the same time as the manifestations of systemic vasculitis in six cases, but preceded it in all others. Allergic rhinitis occurred in 21 of the 30 cases (70 percent) [69] .
Most patients have a fever at some point in their clinical course [67, 69] . Anemia and weight loss are common, as is leukocytosis and elevation of the erythrocyte sedimentation rate [69] . Peripheral blood eosinophilia is seen at some time in each case [69] . The degree of eosinophilia and erythrocyte sedimentation rate elevation are good indicators of disease activity [69] .
Chest Radiographic Manifestations Chest radiographic abnormalities range from transient patchy densities to massive bilateral nodular infiltrates without cavitation to diffuse interstitial disease (Fig. 9 ) [69] [70] [71] . New lesions may appear while older ones are disappearing; some remain stable after an initial period of improvement, while others stabilize without improvement [71] . Complete radiographic regression of a widespread active pulmonary process is sometimes seen with corticosteroids [72] .
Diagnosis and Pathologic Findings Histologically, the lungs typically show fibrinoid, necrotizing, and eosinophilic granulomatous lesions which frequently involve the pulmonary arteries [71] . In about one-half of their cases, Churg and Strauss [67] found parenchymatous lesions in the form of an extensive pneumonic process involving septa and alveoli. In the acute stage, exudate in the lungs had a predominance of eosinophilic leukocytes mixed with giant cells. Histologic evidence of bronchial asthma (hyalinization of basement membrane, increased mucus secretion, and eosinophilic infiltration of the bronchial walls) was present in most cases, but generally was not very marked [67] .
Allergic granulomatosis (Churg-Strauss syndrome) strongly resembles classic polyarteritis nodosa with some obvious distinguishing features. Churg-Struass syndrome almost invariably is associated with an allergic diathesis, particularly severe asthma [31] . Reports of the incidence of asthma with polyarteritis nodosa have ranged from 4 percent to as high as 54 percent [69] . In general, unlike classic polyarteritis nodosa in which pulmonary abnormalities are rare, lung involvement is a sine qua non of the Churg-Strauss syndrome. Also, this syndrome is characterized by high levels of peripheral eosinophilia (usually higher than 1,500 per mm3), eosinophilic tissue infiltration and granulomatous reactivity [31, [67] [68] [69] . In contrast, the predominant cellular infiltrate in polyarteritis nodosa is the neutrophilic leukocyte [69] . In addition to the fibrinoid necrosis of small and medium-sized muscular arteries that is the hallmark of classic polyarteritis nodosa, a substantial degree of involvement of small vessels, such as capillaries and venules, is present in ChurgStrauss syndrome [31] .
The "overlap syndrome" of the systemic vasculitides combines many features that are characteristic of classic polyarteritis nodosa, other systemic vasculitides of the small and medium-sized vessels, such as allergic angiitis and granulomatosis (ChurgStrauss syndrome), and the small-vessel hypersensitivity vasculitides [2, 31] . Large and small arteries, as well as capillaries and venules, may be involved in the vasculitis process. One patient may have features that would be considered characteristic, or even pathognomonic, of either classic polyarteritis nodosa or allergic granulomatosis. The "overlap syndrome" is a multisystem disease with the associated protean clinical manifestations. The same patient may have small-vessel involvement (arterioles, capillaries, and venules), as well as the classic small-and-medium-sized muscular artery involvement with characteristic angiographically demonstrable small aneurysms. A history of allergy, peripheral eosinophilia, eosinophilic tissue infiltration [2] , granulomatous reactions, and lung involvement described for Churg-Strauss syndrome may all be seen in the same patient, or one or more of these may be seen to the exclusion of the others [31] . This syndrome is the most difficult to classify.
Therapy and Prognosis
Well controlled experience with therapy for the Churg-Strauss syndrome is lacking. Chumbley and co-workers treated 27 of their 30 patients with prednisone [69] ; most received 40 to 60 mg daily, others 100 to 120 mg daily. Fifteen of these patients died, three within a year after symptoms of vasculitis appeared [69] . The interval from onset of signs and symptoms of vasculitis to death ranged from 6 months to 15 years, average 4.6 years. Cyclophosphamide and azathioprine therapy have theoretical rationale since they are effective in treating another necrotizing vasculitis, Wegener's granulomatosis. However, experience with these agents is minimal [69] .
CONNECTIVE TISSUE DISEASES The connective tissue (collagen vascular) diseases are a heterogeneous group of chronic inflammatory and immunologically mediated disorders. They share certain clinical characteristics including inflammation of joints, serosal membranes, connective tissue, and blood vessels in various organs [2] . The lung is particularly vulnerable to this group of diseases because of its abundant vasculature and connective tissue [2] . Two of the classic collagen vascular diseases, systemic lupus erythematosus (SLE) and scleroderma, frequently involve both the lungs and the kidneys.
SYSTEMIC LUPUS ERYTHEMATOSUS Systemic lupus erythematosus is a multisystem disease associated with autoimmune antibodies and circulating immune complexes. It is characterized by widespread inflammatory changes in connective tissues, vessels, and serosal surfaces. In contrast to rheumatoid arthritis (RA), another connective tissue disease, renal involvement is common in SLE, and, together with central nervous system disease and infections, often determines survival of these patients [2] .
Although infections are the most common cause of infiltrates in the lungs of patients with SLE, many patients develop infiltrates apparently independent of infection [2, [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] . In fact, the lungs and pleura together are affected more frequently in SLE than in the other connective tissue diseases, the incidence varying in reported series from 50 to The clinical manifestations of pleuropulmonary involvement vary but usually include cough with or without sputum, dyspnea, and pleuritis [2, 73] . Pleural disease is more frequently painful in SLE than RA, and is often associated with fever [2] . Rarely, patients present with mild or overwhelming hemoptysis [79, [97] [98] [99] , and pulmonary involvement may be the initial feature of SLE [73, 77] , as well as one associated with an exacerbation of previously recognized disease [2] .
Hunninghake and Fauci have classified the chest radiographic features of primary pleuropulmonary disease in SLE under six separate categories [2] . Frequently, more than one of these entities is present in an individual patient. Figures 10 and 11 provide typical examples of chest radiographic abnormalities.
(1) Pleuritis and/or Effusion Pleuritis and/or effusion are the most common pleuropulmonary abnormalities in SLE and are probably present at some stage of the disease in at least 50 to 75 percent of patients (Fig. 10) [96] . Frequently painful, pleural disease is often associated with exacerbation of the underlying disorder. Winslow and co-workers [96] stressed the importance of pleuritis as an early manifestation in the diagnosis of SLE. Pleural effusion occurred in 42 of their 57 cases. Although usually bilateral and small, these pleural effusions may be massive [2, 91, 93, 100] . The pleural fluid in SLE is usually an exudate with protein in excess of 3 gm per 100 ml. As in RA, concentrations of complement are generally depressed in the effusion [2] . However, in contrast to RA, pleural fluid glucose concentrations are not markedly depressed [101] , and the total leukocyte count is usually less than in RA [102]. In addition, lupus erythematosus cells are occasionally found [2, 103] . When pleural effusions are present in patients with SLE, it is prudent to obtain samples of this fluid for diagnostic studies because there may be co-existing infection. When another underlying process has been excluded, the patient should be started on corticosteroid therapy, or the current dosage of cortocosteroids should be increased [2] .
(2) Atelectasis Atelectasis, usually in the bases and situated peripherally, is commonly seen on chest radiographs in patients with SLE [73, [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] . The basilar infiltrates frequently are associated with pleuritis, effusion, and/or diaphragmatic dysfunction [104] . The development of basilar atelectasis is analogous to that occurring after abdominal surgery; many of these patients have prolonged pleural pain and splinting [2] . In numerous cases dyspnea and pulmonary function abnormalities are disproportionate to the chest radiographic changes.
(3) Uremic Pulmonary Edema Uremic pulmonary edema is readily established by the presence of a markedly increased concentration of blood urea nitrogen. The chest radiographic findings include fluffy acinar infiltrates that are more pronounced in the perihilar areas and the lower lung zones [2] . Pleural effusion may or may not be present.
(4) Acute Lupus Pneumonitis Acute lupus pneumonitis is a well-recognized manifestation of SLE [73, 82] . The diagnosis, however, is one of exclusion since this entity may be mimicked by atelectasis, uremic pulmonary edema, and secondary infections [2] . These lesions usually appear on chest radiographs as poorly defined areas of increased density or extensive unilateral or bilateral acinar infiltrates (Figs.  11 A,B) [73, [77] [78] [79] 82] . Associated findings include cardiomegaly and pleuritis with or without effusion. Patients with acute lupus pneumonitis characteristically are extremely ill with severe dyspnea, a nonproductive cough, temperature of 100-1040F., tachypnea, and hypoxia [72, 82] . There is no evidence of infection and antimicrobial drugs are ineffective. Although most of these patients respond dramatically to corticosteroids alone, some have improved only after the addition of cytotoxic agents such as azathioprine [73, 77, 79] Eisenberg and co-workers [86] reported 18 SLE patients whose chest radiographs demonstrated diffuse reticulonodular, interstitial infiitrates which were located predominantly in the lower lung zones. These investigators noted that the frequency of these lesions in their outpatient clinic was less than 3 percent [86] . Pulmonary symptoms were dyspnea, a non-productive cough, and pleuritic chest pain. Physical findings included poor diaphragmatic movement and basilar rales. Clubbing was not a feature in these patients. Pulmonary function studies showed a restrictive ventilatory defect with loss of volume, decreased diffusing capacity for carbon monoxide, and hypoxia. Some of these patients responded favorably to corticosteroids [86] . (6) Diaphragmatic Dysfunction Diaphragmatic dysfunction with loss of lung volume only recently has been described as an SLE abnormality [2, 104] . However, elevated diaphragms with "'sluggish" movement and loss of lung volume on chest radiographs have been noted in previous studies [81, 105, 110] . Although fixation of the diaphragms by pleural adhesions was not ruled out conclusively in these studies, the etiology of this disorder is now believed to be diffuse myopathy affecting the diaphragmatic muscles. In addition to decreased lung volumes and diffusing capacity, these patients generally have reduced values for lung elastic recoil pressures at total lung capacity and decreased maximal transdiaphragmatic pressures [2] . An interesting clinical feature of this disorder is dyspnea in the supine position, a symptom associated with diaphragmatic paralysis [2, 111] . Although the natural history of diaphragmatic dysfunction is not entirely clear, the restrictive ventilatory defect is reported to have remained static during periods of four to six years [104] .
As noted, pleuritis, acute lupus pneumonitis, and interstitial lung disease all warrant therapy with corticosteroids [2, 73, 77, 79, 86] . Although no controlled clinical trials are available, generally the response to this therapy is favorable [2, 73] .
At least 50 percent of the pleuropulmonary abnormalities in SLE are secondary to an infectious process [2, 82] . Because infections and renal disease are an important cause of death in such cases, it is critical to obtain appropriate cultures and to perform histopathologic studies.
Pleural effusions and pulmonary infiltrates also are seen in approximately 50 percent of cases of drug-induced, SLE-like syndromes [2, [112] [113] [114] [115] [116] [117] . In fact, the incidence of pleuropulmonary abnormalities in the drug-induced disorder is second only to that of diffuse arthralgias and myalgias, which occur in 75 to 90 percent of patients with this disease. In contrast to cases of idiopathic SLE, once the nature of this disorder is recognized and the offending agent is discontinued, the prognosis, with few exceptions [118] , is excellent [2] .
PROGRESSIVE SYSTEMIC SCLEROSIS (SCLERODERMA) Progressive systemic sclerosis [2, is a multisystem disease of unknown etiology characterized by varying degrees of vascular change and fibrosis and inflammation of skin and internal organs. The skin, gastrointestinal tract, musculoskeletal system, kidneys, heart, and lungs are affected frequently [2, 119, 120] . Although the cutaneous features may dominate the clinical picture, it is the visceral involvement that determines survival.
Among the visceral organs involved in scleroderma, pulmonary disease is second only to esophageal involvement [119] . The true incidence of pulmonary involvement is difficult to determine; however, chest radiographic abnormalities have been described in up to 25 percent of cases [119] [120] [121] . Pulmonary symptoms occur at some time during the course of the illness in 50 percent of patients [119] [120] [121] . In one series utilizing pulmonary function tests, abnormalities were present in 21 of 22 patients [119] . Interstitial fibrosis is found at postmortem examination in nearly all cases [120, . In one postmortem study of 196 cases [120] , pulmonary fibrosis was found in 77 percent, pulmonary vascular disease in 30 percent, and pleural disease in 32 percent.
Clinico-Pathologic Features
The majority of patients are affected in their fourth through sixth decades, and this disease occurs three times more frequently in females than in males [119, 120] . The most prominent symptoms of pulmonary involvement are dyspnea and, less commonly, a cough, which may be slightly productive [119, 120] . Frequently there are fine basilar rales and limited expansion of the chest [119] . Signs of cor pulmonale may appear as a result of pulmonary vascular and interstitial disease. Renal involvement may be extensive, and complications of renal disease ultimately may cause the demise of the patient. Raynaud's phenomenon, often with trophic finger changes, occurs in 80 to 90 percent of patients and may precede other systemic involvement by years [122, 123] . Initial laboratory findings may be nonspecific. Fifty percent of patients have hyperglobulinemia, and positive antinuclear antibodies occur in 50 to 60 percent, often in a nucleolar or speckled pattern [124] .
Sackner and co-workers [121] noted increased pulmonary vascular resistance in all patients who underwent cardiac catheterization. In about one-half of these patients, the increased pulmonary vascular resistance was slight and did not produce clinical or radiographic signs of right ventricular hypertrophy. In the remainder, pulmonary hypertension was accompanied clinically by signs of right ventricular hypertrophy and right ventricular failure [121, 127] .
Pulmonary function abnormalities include a restrictive pattern with reduction of vital capacity [119] [120] [121] and reduced lung compliance. A reduced diffusing capacity for carbon monoxide is often the earliest abnormality noted and may be present prior to recognized chest radiographic abnormalities [126] . Recently, Guttadauria and colleagues [137] radiograph is an interstitial reticular pattern (Fig. 12) particularly affecting the lung bases [ 119] . These basilar changes are due mainly to the recurrent aspiration pneumonia that occurs and in part to the primary disease process. As the disease progresses, the pulmonary infiltration becomes more dense, with subsequent honeycombing and cyst formation. The cysts are most often subpleural in the basal and paravertebral areas and are usually bilateral. Although they tend to be small (5 mm or less in diameter), large cysts may occur and rupture, which produces a pneumothorax [2, 119, 138] . Other findings include micronodulation, increased vascular markings, and pulmonary edema [2, 120] . Disseminated pulmonary calcification or calcification of the soft tissue of the thorax may be seen on chest radiograph. The latter may also demonstrate the presence of pleural thickening, pleural effusion, and signs of pulmonary hypertension secondary to sclerodermatous lung disease (Fig. 12 ) [119, 120] . Disturbance of esophageal motility may result in retention of food and recurrent aspiration pneumonia.
Pathologic Findings Pathologic changes in the lungs frequently occur with or without clinical abnormalities [120, 126, [139] [140] [141] . In an autopsy study, Weaver and co-workers [141] found pulmonary abnormalities in all 28 cases of scleroderma. The most prominent finding was a progressive and nonspecific bilateral interstitial fibrosis of the lower lobe with bronchiolectasis and cyst formation. Marked intimal thickening by loose myxomatous connective tissue occurred in small pulmonary arteries and arterioles. Norton and Nardi emphasized that involvement of the arterioles and capillary bed in many tissues, particularly in the lungs and kidneys, is the basis of scleroderma [139] . They concluded that scleroderma must be regarded as a vascular disease. It is clear that the pulmonary vascular lesions are not merely an extension of interstitial fibrosis, since many scleroderma lungs have areas of severe interstitial fibrosis without arterial lesions, as well as areas of vascular changes without interstitial disease [140] . Other thoracic pathology in patients with scleroderma includes pleural thickening or effusion, cardiomegaly, vascular congestion, pulmonary edema, enlarged pulmonary arteries, and pneumonitis [119] . Therapy and Prognosis Unfortunately, no effective therapy has been found for cases of scleroderma [129, 146] . There is no evidence that corticosteroids or cytotoxic agents alter outcome (Tables 2,3) . A patient with frank hemoptysis, hematuria with renal failure, and a diffuse, bilateral alveolar filling process is most likely to have Goodpasture's syndrome. Rarely, SLE is associated with this clinical constellation, including hemoptysis.
However, the LE cell preparation and/or antinuclear factor are positive in SLE but negative generally in Goodpasture's syndrome (Tables 2,3,4) .
Tissue is required in most cases to distinguish lymphomatoid granulomatosis from Wegener's granulomatosis. However, Churg-Strauss syndrome can be differentiated from the other five pulmonary renal syndromes by the presence of peripheral blood eosinophilia and wheezing (Tables 3,4) .
